X 23 (Alfuzosin Hydrochloride Extended Release 10 mg)
Pill with imprint X 23 is White, Round and has been identified as Alfuzosin Hydrochloride Extended Release 10 mg. It is supplied by Aurobindo Pharma Limited.
Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class alpha-adrenoreceptor antagonists. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for X 23
Alfuzosin Hydrochloride Extended Release
- Imprint
- X 23
- Strength
- 10 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Alpha-adrenoreceptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0249
- Inactive Ingredients
-
carbomer homopolymer type B,
silicon dioxide,
calcium phosphate dibasic anhydrous,
hydrogenated cottonseed oil,
hypromellose 2208 (100 mPa.s),
hypromellose 2910 (5 mPa.s),
magnesium stearate,
povidone k30,
propylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "X 23"
More about alfuzosin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (65)
- Drug images
- Pricing & coupons
- En español
- Drug class: alpha-adrenoreceptor antagonists
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.